Study finds that Ozempic from Novo Nordisk can be obtained for under $5 per month

A photograph of a box of Ozempic and its contents placed on a table in ⁤Dudley, North Tyneside, ‌Britain, on ‌October 31, 2023, is‌ shown in‌ the image. ⁢The study, conducted by researchers at Yale University, ‍King’s College Hospital in⁤ London, and the nonprofit Doctors Without Borders,⁢ suggests that the blockbuster diabetes drug Ozempic could be​ produced ⁢for less than $5 a month, despite Novo Nordisk charging nearly $1,000 per month for the injection in the U.S. before insurance. This study raises concerns about the high price of the top-selling ⁣diabetes treatment and similar drugs for weight loss, which belong to a‌ new class of treatments called‌ GLP-1s. The demand for these medicines ⁣has increased significantly ​over the‌ past year, even as more insurers exclude them ‍from their plans due ‍to ⁣cost, making it difficult for some patients ‌to afford the drugs. The study also follows years of political pressure ​on Novo Nordisk‌ and other ⁤drugmakers to reduce ⁤the high costs of‍ diabetes care, particularly insulin. The‍ article can be found at www.cnbc.com